PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.
Zhu K, Cheng X, Wang S, Zhang H, Zhang Y, Wang X, Chen Y, Wu J.
Zhu K, et al. Among authors: chen y.
Front Endocrinol (Lausanne). 2022 Jan 21;12:706909. doi: 10.3389/fendo.2021.706909. eCollection 2021.
Front Endocrinol (Lausanne). 2022.
PMID: 35126305
Free PMC article.